Insider Trading & Ownership - Xilio Therapeutics Inc. (XLO)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Xilio Therapeutics Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-04-02
Purchase
2024-04-03
6:50 pm
Xilio Therapeutics Inc.XLOGILEAD SCIENCES INC.
10% Owner
485,250$0.76$368,79011,227,923
(Direct)
View
2024-02-08
Sale
2024-02-09
4:33 pm
Xilio Therapeutics Inc.XLOAtlas Venture Fund XI L.P.
Atlas Venture Associates XI L.P.
Atlas Venture Associates XI LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
10% Owner
1,000$0.64$6402,754,109
(Indirect
Direct)
View
2024-01-11
Sale
2024-01-16
6:16 pm
Xilio Therapeutics Inc.XLOAtlas Venture Fund XI L.P.
Atlas Venture Associates XI L.P.
Atlas Venture Associates XI LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
10% Owner
4,235$0.85017$3,6002,755,109
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-01
Option Award
2024-10-02
5:15 pm
N/A
2034-09-30
Xilio Therapeutics Inc.XLOBrennan Kevin M.
SVP, FINANCE AND ACCOUNTING
26,000$026,000
(Direct)
View

Ownership
2024-09-27
9:00 pm
N/A
N/A
Xilio Therapeutics Inc.XLOChudnovsky Yekaterina
GKCC LLC
10% Owner
0$07,000,000
(Indirect)
View
2024-08-03
Option Award
2024-08-06
8:00 pm
N/A
2034-08-02
Xilio Therapeutics Inc.XLOFrankenfield Christopher James
Chief Operating Officer
52,000$052,000
(Direct)
View
2024-06-14
Option Award
2024-06-17
4:30 pm
N/A
2034-06-13
Xilio Therapeutics Inc.XLOXu Yuan
Director
25,000$025,000
(Direct)
View
2024-06-14
Option Award
2024-06-17
4:30 pm
N/A
2034-06-13
Xilio Therapeutics Inc.XLOBonstein Sara
Director
25,000$025,000
(Direct)
View
2024-06-14
Option Award
2024-06-17
4:30 pm
N/A
2034-06-13
Xilio Therapeutics Inc.XLOROSS ROBERT W.
Director
25,000$025,000
(Direct)
View
2024-06-14
Option Award
2024-06-17
4:30 pm
N/A
2034-06-13
Xilio Therapeutics Inc.XLORossi Christina
Director
25,000$025,000
(Direct)
View
2024-06-14
Option Award
2024-06-17
4:30 pm
N/A
2034-06-13
Xilio Therapeutics Inc.XLOClancy Paul J
Director
25,000$025,000
(Direct)
View
2024-06-14
Option Award
2024-06-17
4:30 pm
N/A
2034-06-13
Xilio Therapeutics Inc.XLOCurran Daniel J.
Director
25,000$025,000
(Direct)
View
2024-06-13
Option Award
2024-06-17
4:12 pm
N/A
2034-06-12
Xilio Therapeutics Inc.XLOShannon James Samuel
Director
50,000$050,000
(Direct)
View
2024-06-13
Option Award
2024-06-17
4:10 pm
N/A
2034-06-12
Xilio Therapeutics Inc.XLOBrennan Aoife
Director
50,000$050,000
(Direct)
View
2024-05-01
Option Award
2024-05-03
4:10 pm
N/A
2034-04-30
Xilio Therapeutics Inc.XLOLuptakova Katarina
CHIEF MEDICAL OFFICER
59,333$059,333
(Direct)
View
2024-05-01
Option Award
2024-05-03
4:10 pm
N/A
2034-04-30
Xilio Therapeutics Inc.XLOBrennan Kevin M.
SVP, FINANCE AND ACCOUNTING
20,000$020,000
(Direct)
View
2024-05-01
Option Award
2024-05-03
4:10 pm
N/A
2034-04-30
Xilio Therapeutics Inc.XLOFrankenfield Christopher James
CHIEF OPERATING OFFICER
208,000$0208,000
(Direct)
View
2024-05-01
Option Award
2024-05-03
4:10 pm
N/A
2034-04-30
Xilio Therapeutics Inc.XLORusso Rene
PRESIDENT AND CEO
474,000$0474,000
(Direct)
View

Ownership
2024-04-03
6:48 pm
N/A
N/A
Xilio Therapeutics Inc.XLOGILEAD SCIENCES INC.
10% Owner
0$06,860,223
(Direct)
View
2024-01-01
Option Award
2024-01-03
4:38 pm
N/A
N/A
Xilio Therapeutics Inc.XLOFrankenfield Christopher James
CHIEF OPERATING OFFICER
77,500$077,500
(Direct)
View
2024-01-01
Option Award
2024-01-03
4:15 pm
N/A
N/A
Xilio Therapeutics Inc.XLOLuptakova Katarina
CHIEF MEDICAL OFFICER
66,500$066,500
(Direct)
View
2024-01-01
Option Award
2024-01-03
4:15 pm
N/A
N/A
Xilio Therapeutics Inc.XLOBrennan Kevin M.
SVP, FINANCE AND ACCOUNTING
20,000$020,000
(Direct)
View
2024-01-01
Option Award
2024-01-03
4:15 pm
N/A
N/A
Xilio Therapeutics Inc.XLORusso Rene
PRESIDENT AND CEO
177,000$0177,000
(Direct)
View
2023-09-05
Option Award
2023-09-07
4:26 pm
N/A
2033-09-04
Xilio Therapeutics Inc.XLOLuptakova Katarina
Chief Medical Officer
106,000$0106,000
(Direct)
View

Ownership
2023-09-07
4:23 pm
N/A
2031-12-06
Xilio Therapeutics Inc.XLOLuptakova Katarina
Chief Medical Officer
0$0119,210
(Direct)
View
2023-08-16
Option Award
2023-08-18
8:45 pm
N/A
2033-08-15
Xilio Therapeutics Inc.XLORusso Rene
CEO
700,000$0700,000
(Direct)
View
2023-08-16
Option Award
2023-08-18
8:40 pm
N/A
2033-08-15
Xilio Therapeutics Inc.XLOFrankenfield Christopher James
CHIEF OPERATING OFFICER
300,000$0300,000
(Direct)
View
2023-08-16
Option Award
2023-08-18
8:35 pm
N/A
2033-08-15
Xilio Therapeutics Inc.XLOBrennan Kevin M.
SVP, FINANCE AND ACCOUNTING
25,000$025,000
(Direct)
View
2023-08-16
Option Award
2023-08-18
8:30 pm
N/A
2033-08-15
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
PRESIDENT AND HEAD OF R&D
136,500$0136,500
(Direct)
View
2023-08-03
Option Award
2023-08-07
4:12 pm
N/A
2033-08-02
Xilio Therapeutics Inc.XLOFrankenfield Christopher James
Chief Operating Officer
150,000$0150,000
(Direct)
View

Ownership
2023-08-07
4:09 pm
N/A
2031-03-28
Xilio Therapeutics Inc.XLOFrankenfield Christopher James
Chief Operating Officer
0$0398,172
(Direct)
View
2023-06-12
Option Award
2023-06-13
4:30 pm
N/A
2033-06-11
Xilio Therapeutics Inc.XLOROSS ROBERT W.
Director
13,200$013,200
(Direct)
View
2023-06-12
Option Award
2023-06-13
4:30 pm
N/A
2033-06-11
Xilio Therapeutics Inc.XLOHeyman Tomas J.
Director
13,200$013,200
(Direct)
View
2023-06-12
Option Award
2023-06-13
4:30 pm
N/A
2033-06-11
Xilio Therapeutics Inc.XLOXu Yuan
Director
13,200$013,200
(Direct)
View
2023-06-12
Option Award
2023-06-13
4:30 pm
N/A
2033-06-11
Xilio Therapeutics Inc.XLOBonstein Sara
Director
13,200$013,200
(Direct)
View
2023-06-12
Option Award
2023-06-13
4:30 pm
N/A
2033-06-11
Xilio Therapeutics Inc.XLORossi Christina
Director
13,200$013,200
(Direct)
View
2023-06-12
Option Award
2023-06-13
4:30 pm
N/A
2033-06-11
Xilio Therapeutics Inc.XLOClancy Paul J
Director
13,200$013,200
(Direct)
View
2023-04-01
Option Award
2023-04-03
4:11 pm
N/A
2033-03-31
Xilio Therapeutics Inc.XLOBrennan Kevin M.
SVP, FINANCE AND ACCOUNTING
55,000$055,000
(Direct)
View
Goto 0, 1, 2, Next